value of olaparib in brca-mutated advanced ovarian cancer
Published 6 years ago • 3.2K plays • Length 6:18Download video MP4
Download video MP3
Similar videos
-
11:22
olaparib in ovarian cancer
-
4:17
case 2: olaparib in brca-mutated ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
8:41
parp inhibitors for ovarian cancer: use of olaparib
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
1:10
dr. tripathy on impact of olaparib approval in brca-positive breast cancer
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
1:25
olaparib in ovarian cancer
-
6:43
sequencing parp inhibitors in advanced ovarian cancer
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
4:40
solo-1 and parp inhibitors in ovarian cancer
-
1:48
dr. penson on olaparib monotherapy vs chemo for ovarian cancer
-
2:07
maintenance olaparib in patients with ovarian cancer
-
5:43
using olaparib in gbrca1/2 breast cancer
-
2:48
rationale for olaparib in advanced ovarian cancer
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib